Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.

NCT01711853 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Insufficiency, Chronic

Interventions

DRUG: Dabigatran Etexilate

Sponsor

Boehringer Ingelheim